India’s 1st indigenously developed pneumonia vaccine gets DCGI nod


PTI, Jul 15, 2020, 9:22 PM IST

New Delhi: The country’s first fully indigenously developed vaccine against pneumonia has got approval from the Drug Controller General of India (DCGI), the Union health ministry said on Wednesday.

With the help of Special Expert Committee (SEC) for vaccines, the drug regulator reviewed the phase I, II and III clinical trial data submitted by Pune-based firm Serum Institute of India and then granted the market approval for Pneumococcal Polysaccharide Conjugate Vaccine.

The vaccine is administered in an intramuscular manner.

The ministry said the vaccine will be used for active immunisation against invasive disease and pneumonia caused by ‘Streptococcus pneumonia’ among infants.

The Serum Institute of India first obtained the approval of the DCGI to conduct Phase I, II and III clinical trials of the vaccine in India. These trials have since been concluded within the country. The company also conducted clinical trials in the Gambia.

Thereafter, the company applied for approval and permission to manufacture the vaccine.

The Special Expert Committee (SEC) recommended for grant of permission of market authorization to the said vaccine. On July 14, Serum Institute of India Pvt Ltd was granted permission to manufacture domestically developed first Pneumococcal Polysaccharide Conjugate Vaccine, the ministry said.

“This is the first indigenously developed vaccine in the field of pneumonia,” it said.

Earlier, the demand for such vaccine was substantially met by licensed importers in the country since the manufacturers were all vaccine companies based outside India, the ministry added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

10 month baby gets new heart, new life

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

100 engineering colleges in Karnataka to be ‘adopted’ by corporates by next year: IT Minister Kharge

Siddaramaiah defends BPL ration card cancellation, says only ineligible beneficiaries affected

China announces new policy measures to protect its exports from Trump’s new tariff threat

Renovated Medical Oncology OPD and Chemotherapy Day Care Centre inaugurated at Kasturba Hospital, Manipal

Related Articles More

Mumbai terror accused Rana approaches US Supreme Court to challenge extradition to India

Who will be next Maharashtra CM? Mahayuti, MVA constituents drop different names

PM Modi leaves for home after concluding three-nation visit

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kerala HC quashes FIR against Goa Guv over remarks on Sabarimala women entry

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

Fraudsters create fake FB profile misusing Udupi DC’s identity, case filed

Investigation begins into Naxal Encounter; Where did the others escape?

Mumbai terror accused Rana approaches US Supreme Court to challenge extradition to India

Who will be next Maharashtra CM? Mahayuti, MVA constituents drop different names

Geethartha Chinthane 101: Understanding of universality eases grief

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.